Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 11.11.2021.

Clinical trial
Biotechnology
Pharmacology
Medicine
Emergent BioSolutions
Honor

Career And Jobs

@MALifeSciences shared
On Nov 9, 2021
RT @MassBioEd: On 10/26, we honored 4 #Champs4BioEd at our 6th Awards Reception. Governor Baker provided keynote remarks, and MassBioEd celebrated 20 years of building a talented and diverse life sciences workforce. Watch Gov. Baker's remarks & catch up on the event: https://t.co/K3e5KPNjw8 https://t.co/nEwKKRqVX1
Open
Champions for Biotech Education Awards

Champions for Biotech Education Awards

The Champions for Biotech Education Awards Reception celebrates outstanding advocacy for, and contributions to, life sciences education in New England. Each year, MassBioEd honors an ...

@JohnCendpts shared
On Nov 5, 2021
Thanks for the boost, biotech. Pharma industry reputation now close to biotech industry esteem: Harris Poll By @BethSBulik https://t.co/u2dgWKCBA4
Open
Thanks for the boost, biotech. Pharma industry reputation now close to biotech industry esteem: Harris Poll

Thanks for the boost, biotech. Pharma industry reputation now close to biotech industry esteem: Harris Poll

The pharma industry owes biotech a thank you note. Driven by innovation from biotech companies including Moderna, BioNTech and Regeneron in Covid-19 vaccines and treatments, the pharma ...

@GENbio shared
On Nov 8, 2021
RT @GENBiotechJrnl: It is our pleasure to announce the appointment of the Editor-in-Chief of @GENBiotechJrnl, Dr. Hana El-Samad @HanaScientist, Kuo Family Endowed Professor and Vice Chair in the Department of Biochemistry and Biophysics @UCSF! https://t.co/bCnoevvfD9 1/ https://t.co/NegbaqFaiB
Open
Professor Hana El-Samad, PhD, Appointed Editor-in-Chief of GEN Biotechnology

Professor Hana El-Samad, PhD, Appointed Editor-in-Chief of GEN Biotechnology

News - Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in the most promising areas of ...

@JohnCendpts shared
On Nov 10, 2021
The renowned drug hunter, the Washington insider, the MIT strategist: How did one low-profile biotech enlist a dream team of top biotech advisors? https://t.co/KUUVmn6qHh
Open
The renowned drug hunter, the Washington insider, the MIT strategist: How did one low-profile biotech enlist a dream team of top biotech advisors?

The renowned drug hunter, the Washington insider, the MIT strategist: How did one low-profile biotech enlist a dream team of top biotech advisors?

When you’re heading up a fledgling biotech out to make a name for yourself in the middle of a wild industry boom, there’s one sure way to differentiate yourself that’s bound to attract ...

@MassBio shared
On Nov 9, 2021
For this week's guest blog, we hear from Dr. Anna Baran, CMO and Head of Consulting at @KCR_ClinDev to explore some key elements for #biotechs to consider when seeking a consultancy. Read more on our website: https://t.co/GBGOb1XHsm
Open
What to Consider When Partnering with a Clinical Trial Consultancy: Tips for Biotech Companies

What to Consider When Partnering with a Clinical Trial Consultancy: Tips for Biotech Companies

KCR’s Trial Execution Consultancy often analyzes what needs trigger consulting engagement from our full-service clients. With years of accumulated experience, from landscaping and ...

@JohnCendpts shared
On Nov 8, 2021
John Maraganore steps into a new role at an upstart biotech as the godfather phase of his career takes shape https://t.co/tVX8juXmu9
Open
John Maraganore steps into a new role at an upstart biotech as the godfather phase of his career takes shape

John Maraganore steps into a new role at an upstart biotech as the godfather phase of his career takes shape

John Maraganore isn’t wasting any time shifting to a new post-Alnylam phase in his long biotech career. Startup wunderkind Beam Therapeutics has lured the soon-to-be ex-CEO to its board, ...

@JohnCendpts shared
On Nov 8, 2021
RT @ZacharyBrennan: Once paid $65 million/yr to fan the flames of the opioid epidemic, ex-Purdue CEO Mark Timney has gone on to continue to rake in the cash - incl. $84m when the Medicines Co. got bought (on top of his $10m salary), and now he's jumping into a SPAC - https://t.co/dr1LhcACEu
Open
Small biotech chaired by ex-Purdue CEO Mark Timney jumps into the SPAC lane

Small biotech chaired by ex-Purdue CEO Mark Timney jumps into the SPAC lane

The latest biotech SPAC has landed, and it’s one featuring Purdue Pharma’s former CEO, Mark Timney. Blade Therapeutics announced its plans Monday to reverse merge with the bluntly named ...

@JohnCendpts shared
On Nov 8, 2021
#3 'We were wrong': After ushering Merck KGaA into PD-(L)1 frenzy, oncology chief jumps on mission to 'turbocharge' T cells By @AmberTongPW https://t.co/GiNPMJegNV
Open
'We were wrong': After ushering Merck KGaA into PD-(L)1 frenzy, oncology chief jumps on mission to 'turbocharge' T cells

'We were wrong': After ushering Merck KGaA into PD-(L)1 frenzy, oncology chief jumps on mission to 'turbocharge' T cells

Zhen Su’s love for T cells — which he compares to his high school sweetheart — began long before he took over the oncology development group at Merck KGaA. But it was at the German pharma ...

Read more: Career And Jobs
weekly 11.11.2021
View archives
Back to home

Subscribe to Biotech Essentials - Career and Jobs.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Career and Jobs.
Privacy Policy

Sign up for the weekly Biotech Essentials - Career and Jobs newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Career and Jobs weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy